CEO OF Heal USA
University of Bayreuth Germany
Agewell Biometrics USA
School of Informatics and Computing:IUPUI USA
Debra L. Griffin
Patient Data Exchange,LLC Jackson, Mississippi USA
Chief Strategist Possible NOWu USA
University of Wolverhampton UK
University of Wolverhampton UK
Recommended Global Healthcare Management Conferences
Digital Health 2020
About the Conference
Details of Digital Health 2020 conference in USA :
March 27-28, 2020
By innovating in digital health and care we can support our ambition towards reducing inefficiencies in healthcare delivery, improving access, reducing costs, increasing quality of care, making our health services more person-centred, personalising medicine for each patient's unique needs. It gives people the opportunity to be provided with "smart care" in a homely environment so that they could live in an independent style.
Our mission at Digital Health 2020 is to make healthcare massively better for every human being. This event will support business leaders at the forefront of healthcare through our in-depth research and actionable insights to help navigate the most topical challenges impeding healthcare innovation.
This event will draw hundreds of innovative thinkers across healthcare, technology, big data technology,venture capital, and beyond to confront the most challenging dilemmas in healthcare - and uncover new solutions. Our goal is to fill the gap between individuals and enterprises committed to advancing impactful innovation.
Digital Health 2020 will warmly welcome senior leaders from major healthcare companies - along with selected investors, academics, big data and blockchain specialists ,wearable device companies and startup founders - that explore best practices, deliver practical tools, and disseminate useful information to industry leaders around the topic of Digital tech in healthcare. This Two-day event will include a diverse series of talks, Keynote speech, skill-based workshops with leaders working at the forefront of healthcare innovation.
Track-1. Big Data and Digital Transformation:
Big Data and analytics is an integral part of digital transformation .Many organisations have undergone a digital transformation to adapt the ever-changing digital landscape. They are achieving transformation through their control over Big Data and Analytics, and by using Machine Learning technology. Big data offers organisations the chance to learn more than what has ever been possible about what their customers want. Many health plans still rely on legacy technologies to power their business. This makes them vulnerable to customer-centric, tech-enabled newcomers. But IT leaders have a window of opportunity to unlock system data, enabling care orchestration.
Track-2. Telemedicine and Telehealth:
Telemedicine is the use of telecommunication and information technologies to provide clinical and medical health care at a distance. It helps to eliminate distance barriers and can improve access to clinical services that would often not be consistently available in distant rural communities. It is also used to save lives in critical care and emergency situations. Although there were distant precursors to telemedicine, it is essentially a product of 20th century telecommunication and information technologies. These technologies permit communications between patient and medical staff with both convenience and loyalty, as well as the transmission of medical, imaging and health informatics data from one site to another. It is a process for accurate data collection in digital format and an electronic medical record for data incorporation .Remote transmission Telemedicine is a system for automatically flagging and providing feedback for outlier data.
m-Health is defined as the medical and public health practice supported by mobile devices, such as mobile phones, patient monitoring devices, personal digital assistances and other wireless devices. mHealth is already being used to monitor a variety of conditions including heart disease, diabetes, autism, insomnia and asthma. The WHO/ITU programme aims to assist governments to use mobile components to reinforce their existing national health activities to prevent, manage, and treat non-communicable diseases (NCDs) and their risk factors.
- Reduction in health spending
- Healthy population
- Adoption of existing mHealth services
- Opportunities for Research and Development
- Demonstrates commitment to achieving NCD reduction targets
Global mHealth Market was valued at $10.5 billion in 2014 and is expected to grow at a CAGR of 33.5% during 2015-2020. The mHealth market is in its nascent stage and is expected to yield significant revenues with increasing awareness and favorable regulatory impositions specific to the quality and feasibility of mobile-based medical devices. Penetration of mobile phones in healthcare segment has had a significant impact on the overall healthcare industry.
e- health encompasses much of medical informatics but tends to prioritise the delivery of clinical information, care and services rather than the functions of technologies. Throughout many western national healthcare services, extensive e-Health infrastructures and systems are now viewed as central to the future provision of safe, efficient, high quality, citizen-centred health care. e- Health market growth is attributed to the transition of the healthcare industry into the digital healthcare system for patient’s management and analysis of health.
The global electronic health (e Health) market is growing at a swift pace and is projected to witness robust growth in the coming years. Technological developments, innovations, and the use of electronic devices are augmenting the global e Health market. The increasing adoption of these systems by medical practitioners across the globe is anticipated to offer promising opportunities for prominent players in the market. Global e Health market is expected to reach USD 308.0 billion by 2022, according to a new report by Grand View Research Inc. The transition of the healthcare industry into digital healthcare system for management and analysis of patient health is expected to be the most vital driver of the market.
Track-5.Bioinformatics and Digital Health:
Nowadays, it goes without saying that the use of information technology is important, even necessary, in the field of life sciences.
The amount of information that needs to be processed, analysed, stored, and represented is constantly growing. These data must then be integrated, compared, and viewed alongside other data to further knowledge and generate added value. Even beyond the issues presented by managing data and the effort required to process this information, the challenge is to improve the capacity of researchers to develop new hypotheses, produce innovative models, and test them.
Bio-Informatics and Information Management professionals are experts in managing the collection, storage, retrieval, analysis and interpretation of health care data and information. To provide the highest quality health care delivery, health care information is used not only for patient care, but also for medical legal issues, reimbursement, research, planning and evaluation. Opportunities for employment are found in a variety of settings, including hospitals, clinics, rehabilitation centers, home health agencies, health maintenance organizations, insurance agencies, governmental agencies, educational institutions and research centers.
Track-6. Digital Health Technologies:
Catagories that come under this group include:
Track 8.Clinical Research & Clinical Trials:
Clinical Trial is a part of clinical research that follows a regulated protocol or a plan of action. They are primarily performed to get data on safety and efficacy of the new developed drug , this data is mandatory for further approval of the drug and to bring it to the market.
The clinical trials market has been estimated to reach USD 14.2 billion in 2016 and is projected to reach around USD 22 billion by the year 2021, growing at a CAGR (compounded annual growth rate) of 7.5%, during the forecast period 2016 to 2021. Key drivers impacting the market growth are globalization of clinical trials, development of new treatments such as personalized medicine, augmenting evolution in technology, and boosting demand for CROs to conduct clinical trials. Clinical studies can be sponsored, or funded, by pharmaceutical companies, academic medical centers, voluntary groups, and other organizations, in addition to Federal agencies such as the National Institutes of Health, the U.S. Department of Defense, and the U.S. Department of Veterans Affairs. Doctors, other health care providers, and other individuals can also sponsor clinical research.
Track-9. Genomics & Precision Medicine:
Precision medicine makes use of variations in consumers genes, environment, and lifestyle to guide the prevention, diagnosis, and treatment of diseases. The potential for precision medicine to radically transform the healthcare industry is driving interest among a range of companies and government organizations. . Firms are flocking to develop the tools needed to extract, store, share, and analyze genomic data. The global precision medicine market is expected to grow at an annualized rate of 12% over 7 years to reach $88.6 billion by 2022, up from $39 billion in 2015, according to Market Research Future.
Track-10.Electronic Health record:
An electronic Health record (EHR) is a person's legitimate health archive that is shared among numerous offices and organizations. The importance of EHRs is getting to be expanding compelling as more patient data winds up computerized and bigger quantities of consumers express a craving to have portable access to their Health records. Among other types of data, an EHR typically contains:
Contact information; Information about visits to healthcare professionals; Insurance information; Family history; Immunization status; Information about any conditions or diseases; A list of medications; Records of hospitalization; Information about any surgeries or procedures performed.
Medical informatics is the application of computers, communications and information technology and systems to all fields of medicine - medical care, medical education and medical research. The definition of Medical Informatics is dynamic due to the rapidly changing nature of both medicine and technology the sharing of a variety of information back and forth between people and healthcare entities. Medical Informatics is a new, exciting and evolving field. New specialties and careers are now possible. The expectation is that information technology will improve medical quality, patient safety, educational resources and patient-physician communication, while decreasing cost. Applied Medical Informatics studies the dispensation of medical statistics, the potent, management of information using computer technology, and the impact of such methods on medical research, education.
Telesurgery additionally called as Remote surgery. Telesurgery is a capacity for a specialist to perform surgery on a patient despite the fact that they are not physically in a similar area. The principal genuine and complete remote surgery was led on 7 September 2001 over the Atlantic Ocean, with French specialist (Dr. Jacques Marescaux) in New York City playing out a cholecystectomy on a 68-year-old female patient 6,230 km away in Strasbourg, France. It was named Operation Lindbergh.
Remote telesurgery rises above the majority of the topographical limitations on specialized surgery. A man at the South Pole requiring surgery can have it there by remote telesurgery ("polar telesurgery"). A space traveller can be worked upon in a space station ("astrosurgery"). What's more, individuals in developing countries will have the capacity to profit by particular developing and not leave home for it.
Track-13.Drug Discovery & Drug Screening:
Reverse pharmacology includes drug screening deals with reverse pharmacology and forward pharmacology are two approaches to drug discovery. Target based drug discovery is the process through which potential new medicines are identified. It involves a wide range of scientific disciplines, including biology, chemistry and pharmacology, screening of chemical libraries and its pharmacology, methods to determine biological targeting, by systematically perturbing and interrogating biological pathways with synthetically novel chemical tools, preclinical validation of target biology is beginning to illuminate a more cost-effective and efficient paradigm for the development of novel drugs modulating novel targets.
- Reverse pharmacology
- Target based drug discovery
- Screening of chemical libraries and its pharmacology
- Classical pharmacology
- Biotransformation of chemicals
- Food and chemical toxicology
- Food safety and toxicology
- Food and cosmetic toxicology
Track-14.Bio Medical Informatics:
Bio Medical Informatics is the use of biomedical data, information and knowledge for scientific inquiry, problem solving, and decision making, motivated by efforts to improve human health. It helps to eliminate distance barriers and can improve access to clinical services that would often not be consistently available in distant rural communities. These technologies permit communications between patient and medical staff with both convenience and loyalty, as well as the transmission of medical, imaging and health informatics data from one site to another. It is a process for accurate data collection in digital format and an electronic medical record for data incorporation.
Track-15. Artificial Intelligence and Digital Health
Track-16. Blockchain Technology
The aim of the conference is to bring together a multidisciplinary spectrum of researchers, industry/start-ups and healthcare practitioners. Submissions are welcome from the range of stakeholders involved in digital health including:
- Health informaticians , Computer scientists,
- Public health experts, epidemiologists, clinicians
- National and international public Health Agencies
- Epidemic intelligence systems providers
- NGOs and Agencies
- Industry and startups, Med tech, IT/SM industry, pharmaceutical industry
- Block-chain Specialists
- Big Data Scientists
- Bio-Medical Technologists
- Clinical Data Managers/Associates
- Bioinformatics and Digital Health Specialists
In 2016, the global digital health market was at $179.6 billion, according to Transparency Market Research (TMR). Growth in this market is anticipated to rise at a CAGR of 13.4% between 2017 and 2025, reaching $536.6 billion by the end of 2025. Over the next few years, TMR says the market will be supported by technology advancements in the medical and healthcare infrastructure.
Past Conference Report
Digital Health Conference 2019
We are delighted to all our Organizing Committee Members, Keynote Speakers, Speakers, Delegates, Students, Exhibitor and Media partners for making our Past Digital Health 2019 Conference in USA Region with great Pride.
- International Conference on Digital Health, 24-25 April,2019 Houston, Texas
Past Conference Report
Digital Health 2019
- Conference Series LLC Ltd hosted the “International Conference on Digital Health” (Digital Health 2019) during 24-25 April,2019 Houston, Texas.
Digital Health 2019 is specifically premeditated with a unifying axiom providing platform to widen the imminent scientific discoveries in the field of Pharmaceutical Research and Development and to deliver novel ideas besides incorporating better understanding of their role in Pharma, Drug Manufacturers, Business Management and Marketing. The scientific meeting has laid the path for the development and the validation of Pharmaceutical Research and Development under the theme of “An Innovative Bridging for Modern Healthcare”
Digital Health 2019 meeting's first day, highlighted boards on Tele Medicine, Medical Informatics, Digital Health, Bio Medical Informatics, Health Data Analytics, Pediatrics Health, Neonatology and Perinatology, Pediatric Neurology and Psychological Disorders and Pediatrics Gastroenterology and Hepatology.
The subsequent day started with a quick notice session on the region of Medical informatics, a clinical choice emotionally supportive network for diabetes utilizing choice tree, a PC put together framework for anticipating with respect to going pregnancy after in vitro preparation, The 3D Musculoskeletal model of deltoid muscle with mechano-compound wonders, Case history of cystic fibrosis kids with iron deficiency on the foundation of intense CMV contamination. The meeting closed with the publication session.
Universal Conference on Digital Health upheld by the sorting out board system of famous logical and proficient master, for example, Alexis Normand, VP of Healthcare - Digital Health Healthcare, United States, Nick Desai, fellow benefactor and CEO Heal, United States, Christian Milaster, Principal | Master Builder of Telehealth Programs IBM Global Services and the Mayo Clinic, United States. It gave a stage to coordinated effort among associates, sellers, and the scholarly community to uncover new advancements, arrangements, thoughts, and developing innovations in Digital Health.
Past Conference Speakers:
Henry Ines, Shivom, USA
Ryan Shaw, Blockade Technologies, USA
Alexis Normad, Embleema Health, USA
Elizabeth Berryman, Chnnl Ltd, New Zealand
Meenalosini Vimal Cruz, Keene State College, USA
Debra Griffin & Dean Harrison, Patient Data Exchange LLC, USA
Michelle Yang, Gene Information Ltd., UK
Ezikel Chinyio & Silvia Riva, University of Wolverhampton, UK
Nick Desai, Heal, USA
Joshua Wies, Agewell Biometrics Inc., USA
Won Deborah, California State University, USA
Samar Singla, JungleWorks, USA
Stephen Ayre, Metro South Health, Australia
Mohamad Ammar Ayass, Ayass Bioscience, LLC, USA
Raj Pallapothu, Bayer, USA
Mohamad Ammar Ayass, Ayass BioScience LLC, USA
Sunandan Chakraborty, Indiana University, USA
Kasthuribai Viswanathan & Kevin Zhu, Ayass Bioscience, LLC, USA
Eric Holzclaw, PossibleNOW, USA
Christian Maier, University of Bayreuth, Germany
Mahrin Rahman, Burrell College of Osteopathic Medicine, USA
Cotty Eslous Marine, LUCINE, France
Charles Chukwumeka Onoh, Federal University of Technology, Nigeria
Past Reports Gallery